Chronic Cough: Novel Therapies on the Horizon to Reduce Burden and Improve Quality of Life

Released On
December 22, 2021

Expires On
December 21, 2022

Media Type
Internet

Completion Time
45 minutes

Specialty
Pulmonology

Topic(s)
Chronic Cough

Scroll to the Bottom of this Information to Begin this Course

This continuing medical education activity is provided by:

This activity is supported by an educational grant from Merck & Co., Inc.

Credit Available

  • Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

The intended audience for this activity is pulmonologists, pulmonology nurse practitioners, and other health care professionals involved in the management of patients with chronic cough.

Program Overview

Chronic cough lasting more than 8 weeks impacts over 10% of the US population. While chronic cough may be associated with any number of pulmonary or extrapulmonary conditions, 70% of patients with chronic cough experience at least 3 clinical encounters to obtain a diagnosis and many go undiagnosed. Additionally, over half of patients who receive treatment note that their symptoms remain uncontrolled, significantly affecting daily activities, sleep, and quality of life. With new agents on the horizon for managing chronic cough, it is imperative that clinicians have a mechanistic understanding of chronic cough and are able to identify patients who may benefit from emerging therapies. In this educational symposium, featuring a rapid-fire panel discussion, experts will examine the burden of chronic cough on patient quality of life, assess underlying causes of chronic cough, and review the data on current and emerging treatment strategies.

Learning Objectives

Upon completion of this activity, participants should be better able to:
  • Examine the burden of chronic cough and impact on patient quality of life.
  • Assess the underlying causes of chronic cough and strategies to recognize patients with the condition.
  • Review the clinical trial data regarding treatment options for refractory chronic cough.

 

Activity Chair

FACULTY_NAME

Peter Dicpinigaitis, MD, FCCP

Professor of Medicine, Albert Einstein College of Medicine
Division of Critical Care Medicine, Montefiore Medical Center
Director, Montefiore Cough Center
Bronx, NY

Faculty

FACULTY_NAME

Michael S. Blaiss, MD, FAAAAI, FACAAI

Clinical Professor of Pediatrics
Medical College of Georgia at Augusta University
Executive Medical Director, American College of Allergy, Asthma, and Immunology
Augusta, GA

FACULTY_NAME

Rachel M. Taliercio, DO

Assistant Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director for Clinical Operations
Department of Pulmonary Medicine, Respiratory Institute
Patient Experience Officer, Respiratory Institute
Cleveland, OH

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

Disclosures of Conflicts of Interest

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Relationship information is accurate at the time of content development.

Peter Dicpinigaitis, MD, FCCP
  • Consulting Fee: Bayer, Bellus, Chiesi, Merck, Shionogi
Michael S. Blaiss, MD, FAAAAI, FACAAI
  • Consulting Fee: ALK, Covis, Merck, Pfizer, Sanofi/Regeneron
Rachel M. Taliercio, DO
  • Consulting Fee: Merck

Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP: No relevant financial relationships to disclose

Vindico Medical Education staff have no relevant financial relationships to disclose.

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Instructions for Participation and Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Disclaimer

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com